Clinical and lymphocyte responses to beta-carotene supplementation in 11 HIV-positive patients with chronic oral candidiasis

Oral Surg Oral Med Oral Pathol. 1994 Oct;78(4):442-7. doi: 10.1016/0030-4220(94)90035-3.

Abstract

Eleven HIV-positive patients with chronic oral candidiasis were supplemented with 60 to 120 mg of beta-carotene daily for 3 to 7 months. Lymphocyte profiles were evaluated at intervals to help assess immune competence. Although there was a modest increase in some lymphocyte values at 2 months, there was a significant decrease in numbers of CD4 and CD8 cells and CD4 percentage of lymphocytes after 6 months of beta-carotene supplementation. Serum triglyceride and liver enzyme levels were not affected by the beta-carotene supplementation. No improvement was observed in the control of the oral candidiasis. Under the conditions of the study, there was no indication that daily beta-carotene supplements enhanced immune competence or was of benefit in managing oral candidiasis.

Publication types

  • Clinical Trial

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy*
  • Adult
  • Analysis of Variance
  • CD4 Lymphocyte Count / drug effects
  • Candidiasis, Oral / drug therapy*
  • Candidiasis, Oral / etiology
  • Carotenoids / blood
  • Carotenoids / therapeutic use*
  • Chronic Disease
  • Female
  • HIV Seropositivity
  • Humans
  • Lipids / blood
  • Lymphocyte Count / drug effects*
  • Lymphocytes / drug effects*
  • Male
  • Middle Aged
  • Treatment Outcome
  • beta Carotene

Substances

  • Lipids
  • beta Carotene
  • Carotenoids